Interventional Imaging

A subspecialty of interventional radiology (IR) uses image-guided, minimally-invasive procedures to diagnose and treat various diseases. Interventional radiologists rely on angiography, mobile C-arm and fluoroscopy imaging systems to perform thrombolysis, embolization, biopsies, vascular and other minimally invasive procedures, which can reduce recovery time, risk and costs. Find more IR content on the Society of Interventional Radiology (SIR) page.

Thumbnail

Researchers examine growth of nonphysician practitioners in radiology

A new paper in the Journal of the American College of Radiology digs into the emergence of physician assistants and nurse practitioners in radiology and how it has impacted clinical and procedural volumes and imaging interpretation.

Thumbnail

Do image-guided corticosteroid injections impact COVID risk?

Patients who received an injection had an infection rate of 2.2% at 4-month follow-up. In comparison, the infection rate for the general population in Massachusetts was 7.5% during the same period.

Thumbnail

25% of patients undergoing transthoracic needle biopsy experience complications

Higher complication rates were observed in inpatient settings and in patients with COPD. Also associated with increased adverse events were prior lung cancer screening and the use of oral anticoagulants or antiplatelets.

A comparison between a traditional iodine contrast angiogram (left), and a gadolinium contrast angiogram (right). MRI gadolinium contrast is starting to be used in some interventional radiology procedures and is being considered in interventional cardiology due to the iodine contrast shortage.

Gadolinium can be used as substitute for iodine contrast in some interventional imaging procedures

Gadolinium might be an alternative, stop-gap solution for interventional procedures during the current iodine contrast shortage.

The imaging iodine contrast shortage is delaying procedures and causing rationing at hospitals. impact is it having on hospitals and the tough decisions that are being made to triage patients to determine if they will get a contrast CT scan or an interventional or surgical procedure requiring contrast. Photo by Dave Fornell

VIDEO: Imaging contrast shortage is delaying procedures and causing rationing

Alan H. Matsumoto, MD, chair of the department of radiology at the University of Virginia and vice chair of the American College of Radiology Board of Chancellors, explains the contrast shortage situation and the tough decisions providers are being forced to make.

Alan Matsumoto explains gadolinium as substitute for iodine contrast during shortage

VIDEO: Gadolinium being substituted for iodine contrast in some procedures due to shortage

Alan H. Matsumoto, MD, chair of the department of radiology at the University of Virginia, vice chair of the American College of Radiology (ACR) Board of Chancellors, and chairman of the ACR Commission on Interventional and Cardiovascular Radiology, explains that the iodine contrast shortage has led to use of MRI gadolinium contrast agents in some cases.

Kirk Garratt, past SCAI president, explains the impact of the iodine contrast shortage on interventional cardiology and the cath lab. #SCAI

VIDEO: How the iodine contrast shortage is impacting interventional cath labs

Kirk Garratt, MD, medical director of the Center for Heart and Vascular Health, ChristianaCare, and a past president of SCAI, explains what this shortage means for interventional cardiologists.

Thumbnail

VIDEO: Cardiology getting more involved in pulmonary embolism response teams

Terry Bowers, MD, director of vascular medicine at Beaumont Hospital and national co-chair of the Pulmonary Embolism Research Collaborative (PERC), explains the trend toward creating pulmonary embolism (PE) response teams that include cardiology. 

Around the web

The newly approved PET radiotracer is expected to improve patient care significantly. “We have been able to reach the pinnacle of myocardial perfusion imaging with flurpiridaz," one expert said.

GE HealthCare's flurpiridaz, the PET radiotracer that recently received FDA approval, offers several key benefits over SPECT. Jamshid Maddahi, MD, discussed the details in an exclusive interview. 

Ultrafast MCE could go on to become a go-to treatment option for obstructive coronary artery disease, according to the authors of a new first-in-human clinical study.

Trimed Popup
Trimed Popup